SUSAN SCHOENEMAN: Open Payments
NPI 1386991636 · SCOTTSBLUFF, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 33 payments from 16 companies in 2025. Trend: 2023 $1,623 · 2024 $1,087 · 2025 $833
Food & beverage: $530Education: $303
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $232 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| ABBVIE INC. | 4 | $81 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $52 |
| Stemline Therapeutics Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Daiichi Sankyo Inc. | 1 | $25 |
| TerSera Therapeutics LLC | 1 | $24 |
Products named: OPDIVO, ENHERTU, RYBREVANT, Orserdu, KEYTRUDA, JEMPERLI, MAVYRET, ELAHERE.
Industry payments across NE — which companies pay providers there.
